ADMA Biologics ADMA Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- ADMA Biologics (ADMA) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 1.5M in Q1 2026.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- The number of potential common shares from stock options, warrants, or restricted stock units that are excluded from the diluted earnings per share calculation because their inclusion would be antidilutive. This provides transparency into potential future share dilution that is currently excluded due to market price conditions.